Abstract
Non-compliance and non-persistence with medication represent a significant problem of realizing the optimal disease management in chronic obstructive pulmonary disease (COPD). Underuse and overuse are both important factors of inadequate therapy. Poor compliance increases the frequency of exacerbations, the number of hospitalizations, results in higher mortality and reduced quality of life. When prescribing medication, besides patient characteristics, the expected compliance and persistence should also be considered. Patient education and a better clinician- patient relationship should increase the effectiveness of treatments.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
[1]. Jonas, J.: Epidemiological data of pulmonary diseases in Hungary (In Hungarian). Korányi National Institute of Tuberculosis and Pulmonology, 2008.
-
[2]. F. Holguin E. Folch S. C. Redd et al.2005 Comorbidity and mortality in COPD-related hospitalizations in the United States 1979–2001 Chest 128 2005–2011.
-
[3]. K. F. Rabe S. Hurd A. Anzueto et al.2007 Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am. J. Respir. Crit. Care Med. 176 532–555.
-
[4]. WHO: Adherence to Long-Term Therapies: Evidence for Action. World Health Organization, 2003, pp. 1–59.
-
[5]. C. R. Regueiro M. B. Hamel R. B. Davis et al.1998 A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: resource intensity, hospital costs, and survival Am. J. Med. 105 366–372.
-
[6]. J. Bourbeau S. J. Bartlett 2008 Patient adherence in COPD Thorax 63 831–838.
-
[7]. T. A. R. Seemungal G. C. Donaldson E. A. Paul et al.1998 Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 157 1418–1422.
-
[8]. L. Gulácsi 2005 Health Economics (In Hungarian) Medicina Press Budapest.
-
[9]. Haynes, R. B., Montague, P., Oliver, T. et al.: Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst. Rev., 2000, 2. CD000011.
-
[10]. I. Cleemput K. Kesteloot S. DeGeest 2002 A review of the literature on the economics of noncompliance. Room for methodological improvement Health Policy 59 65–94.
-
[11]. J. A. Cramer A. Roy A. Burrell et al.2008 Medication compliance and persistence: terminology and definitions Value Health 11 44–47.
-
[12]. A. M. Peterson D. P. Nau J. A. Cramer et al.2007 A checklist for medication compliance and persistence studies using retrospective databases Value Health 10 3–12.
-
[13]. J. Kennedy I. Tuleu K. Mackay 2008 Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed J. Manag. Care Pharm. 14 553–560.
-
[14]. N. S. Breekveldt-Postma C. M. J. M. Gerrits J. W. J. Lammers et al.2004 Persistence with inhaled corticosteroid therapy in daily practice Respir. Med. 98 752–759.
-
[15]. E. Jung A. S. Pickard J. W. Salmon et al.2009 Medication adherence and persistence in the last year of life in COPD patients Respir. Med. 103 525–534.
-
[16]. J. A. Cramer A. Benedict N. Muszbek et al.2008 The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review Int. J. Clin. Pract. 62 76–87.
-
[17]. N. S. Breekveldt-Postma J. Koerselman J. A. Erkens et al.2007 Enhanced persistence with tiotropium compared with other respiratory drugs in COPD Respir. Med. 101 1398–1405.
-
[18]. J. A. Cramer C. Bradley-Kennedy A. Scalera 2007 Treatment persistence and compliance with medications for chronic obstructive pulmonary disease Can. Respir. J. 14 25–29.
-
[19]. R. D. Restrepo M. T. Alvarez L. D. Wittnebel et al.2008 Medication adherence issues in patients treated for COPD Int. J. COPD 3 371–384.
-
[20]. K. Krigsman J. Moen J. L. G. Nilsson et al.2007 Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period J. Clin. Pharm. Ther. 32 603–611.
-
[21]. K. Krigsman J. L. G. Nilsson L. Ring 2007 Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions Pharmacoepidemiol. Drug Saf. 16 441–448.
-
[22]. J. Yeo G. Karimova S. Bansal 2006 Co-morbidity in older patients with COPD — its impact on health service utilisation and quality of life, a community study Age Ageing 35 33–37.
-
[23]. K. Krigsman J. L. G. Nilsson L. Ring 2007 Adherence to multiple drug therapies: refill adherence to concomitant use of diabetes and asthma/COPD medication Pharmacoepidemiol. Drug Saf. 16 1120–1128.
-
[24]. Z. M. Corden C. M. Bosley P. J. Rees et al.1997 Home nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of life Chest 112 1278–1282.
-
[25]. J. George D. C. M. Kong R. Thoman et al.2005 Factors associated with medication nonadherence in patients with COPD Chest 128 3198–3204.
-
[26]. C. S. Rand 2005 Patient adherence with COPD therapy Eur. Respir. Rev. 14 97–101.
-
[27]. J. G. Van Manen P. J. E. Bindels F. W. Dekker et al.2002 Risk of depression in patients with chronic obstructive pulmonary disease and its determinants Thorax 57 412–416.
-
[28]. A. J. Apter S. T. Reisine G. Affleck et al.1998 Adherence with twice-daily dosing of inhaled steroids: socioeconomic and health-belief differences Am. J. Respir. Crit. Care Med. 157 1810–1817.
-
[29]. C. V. Chambers L. Markson J. J. Diamond et al.1999 Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices Respir. Med. 93 88–94.
-
[30]. M. R. Dimatteo 1991 Psychology of Health Illness and Medical Care: An Individual Perspective Thomson Brooks/Cole California.
-
[31]. F. Onyirimba A. Apter S. Reisine et al.2003 Direct clinician-to-patient feedback discussion of inhaled steroid use: its effect on adherence Ann. Allergy Asthma Immunol. 90 411–415.
-
[32]. W. C. Bailey J. M. Richards C. M. Brooks et al.1990 A randomized trial to improve self-management practices of adults with asthma Arch. Intern. Med. 150 1664–1668.
-
[33]. C. Put O. Van den Bergh V. Lemaigre et al.2003 Evaluation of an individualised asthma programme directed at behavioural change Eur. Respir. J. 21 109–115.
-
[34]. A. E. Hesselink B. W. J. H. Penninx D. A. W. M. Van Der Windt et al.2004 Effectiveness of an education programme by a general practice assistant for asthma and COPD patients: results from a randomised controlled trial Patient Educ. Couns. 55 121–128.
-
[35]. F. Gallefoss 2004 The effects of patient education in COPD in a 1-year follow-up randomised, controlled trial Patient Educ. Couns. 52 259–266.
-
[36]. H. Worth Y. Dhein 2004 Does patient education modify behaviour in the management of COPD? Patient Educ. Couns. 52 267–270.
-
[37]. A. A. Petrilla J. S. Benner 2003 Critical evaluation of interventions to enhance patient compliance with chronic medications Value Health 6 200.
| Clinical and Experimental Medical Journal | |
|---|---|
| Language | English |
| Size | |
| Year of Foundation |
2007 |
| Publication Programme |
ceased |
| Volumes per Year |
|
| Issues per Year |
|
| Publisher | Akadémiai Kiadó |
| Publisher's Address |
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245 |
| Responsible Publisher |
Chief Executive Officer, Akadémiai Kiadó |
| ISSN | 2060-6249 (Print) |
| ISSN | 2060-968X (Online) |
Monthly Content Usage
| Abstract Views | Full Text Views | PDF Downloads | |
|---|---|---|---|
| Oct 2022 | 2 | 0 | 0 |
| Nov 2022 | 0 | 0 | 0 |
| Dec 2022 | 12 | 0 | 0 |
| Jan 2023 | 7 | 0 | 0 |
| Feb 2023 | 2 | 0 | 0 |
| Mar 2023 | 3 | 0 | 0 |
| Apr 2023 | 0 | 0 | 0 |
Copyright Akadémiai Kiadó
AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.
Copyright Akadémiai Kiadó AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.
Powered by PubFactory